Spongipregnoloside A

1-[(3S,8S,9S,10R,13S,14S,17S)-3-[(2R,4S,5S)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,5R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone

RNGPDKGOULTCGD-KVQIRICTSA-N CHEBI:166783 0 Reactome links 2 studies

Metabolite details

Identifier: RNGPDKGOULTCGD-KVQIRICTSA-N
InChI Key: RNGPDKGOULTCGD-KVQIRICTSA-N
IUPAC name: 1-[(3S,8S,9S,10R,13S,14S,17S)-3-[(2R,4S,5S)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3S,5R)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]ethanone
Preferred name: Spongipregnoloside A
INN name: —
Synonym: —
ChEBI: CHEBI:166783

Reactome pathways

No Reactome pathways listed for this metabolite.

Observed in studies

Mechanism of interventional effect and targets of Zhuyu Pill in regulating and suppressing colitis and cholestasis
Alterations in the gut microbiota and metabolomics of seafarers after a six-month sea voyage

Observed in differential profiles

Control_vs_ZYP_High_Dose
Control_0d_vs_Treatment_180d